High Expression of LMTK3 is an Independent Factor Indicating a Poor Prognosis in Estrogen Receptor α-Positive Breast Cancer Patients

被引:5
|
作者
Asano, Tomoko [1 ]
Sato, Shinya [2 ,3 ]
Yoshimoto, Nobuyasu [1 ]
Endo, Yumi [1 ]
Hato, Yukari [1 ]
Dong, Yu [1 ]
Takahashi, Satoru [2 ]
Fujii, Yoshitaka [1 ]
Toyama, Tatsuya [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi 4678601, Japan
[3] Nagoya City East Med Ctr, Div Diagnost Pathol, Nagoya, Aichi, Japan
关键词
breast cancer; LMTK3; polymorphism; ENDOCRINE RESISTANCE; TAMOXIFEN RESISTANCE; BINDING; MUTATIONS;
D O I
10.1093/jjco/hyu113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Over 70% of breast cancers are estrogen receptor alpha-positive, and endocrine therapy targeting estrogen action decreases mortality from breast cancer. Recently, a novel protein kinase that regulates estrogen receptor alpha activity, lemur tyrosine kinase-3, has been identified. In this study, we investigated whether messenger RNA expression and polymorphisms of the gene encoding the kinase, LMTK3, are associated with prognosis in breast cancer patients during long-term follow-up. Methods: First, we investigated the relationship between messenger RNA expression of LMTK3 and patient outcome in 219 breast cancers. The effects of several variables on survival were tested by Cox proportional hazards regression analysis. Next, we performed LMTK3 genotyping in 471 breast cancers to clarify the prognostic role of these polymorphisms. Results: Our data showed that LMTK3 expression level was not associated with prognosis in all patients. We then analyzed the impact of LMTK3 mRNA expression on the prognosis of breast cancer according to estrogen receptor alpha status. Both disease-free survival and overall survival were significantly shorter in estrogen receptor alpha-positive patients with high LMTK3 expression receiving adjuvant endocrine therapy than in those patients with low LMTK3 expression. Multivariate Cox regression analysis revealed that high LMTK3 expression was an independent poor prognostic factor in estrogen receptor alpha-positive breast cancer patients. We did not find any correlation between LMTK3 genotypes and prognosis of breast cancer patients in our series. Conclusions: Our results show that high expression of LMTK3 is an independent prognostic factor in estrogen receptor alpha-positive breast cancer patients receiving adjuvant endocrine therapy.
引用
收藏
页码:889 / 897
页数:9
相关论文
共 50 条
  • [31] Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer
    Robin M Hallett
    John A Hassell
    BMC Cancer, 14
  • [32] Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer
    Hallett, Robin M.
    Hassell, John A.
    BMC CANCER, 2014, 14
  • [33] Increased Expression of Fibroblastic Growth Factor Receptor 2 Is Correlated With Poor Prognosis in Patients With Breast Cancer
    Sun, Shanshan
    Jiang, Yongdong
    Zhang, Guoqiang
    Song, Hongtao
    Zhang, Xianyu
    Zhang, Youxue
    Liang, Xiaoshuan
    Sun, Qian
    Pang, Da
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (08) : 773 - 779
  • [34] Prognosis of operable breast cancer in young patients treated in a single Institution: independent pejorative value of positive Estrogen Receptor
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 130 - 130
  • [35] Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer
    Wen-Ting Peng
    Xin Hu
    Ling Yao
    Yi-Zhou Jiang
    Zhi-Ming Shao
    Annals of Surgical Oncology, 2014, 21 : 648 - 656
  • [36] Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer
    Peng, Wen-Ting
    Hu, Xin
    Yao, Ling
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S648 - S656
  • [37] Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients
    Johanna G. H. van Nes
    Esther M. de Kruijf
    Hein Putter
    Dana Faratian
    Alison Munro
    Fiona Campbell
    Vincent T. H. B. M. Smit
    Gerrit-Jan Liefers
    Peter J. K. Kuppen
    Cornelis J. H. van de Velde
    John M. S. Bartlett
    Breast Cancer Research and Treatment, 2012, 133 : 49 - 59
  • [38] KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
    Kammerer, Sarah
    Sokolowski, Armin
    Hackl, Hubert
    Platzer, Dieter
    Jahn, Stephan Wenzel
    El-Heliebi, Amin
    Schwarzenbacher, Daniela
    Stiegelbauer, Verena
    Pichler, Martin
    Rezania, Simin
    Fiegl, Heidelinde
    Peintinger, Florentia
    Regitnig, Peter
    Hoefler, Gerald
    Schreibmayer, Wolfgang
    Bauernhofer, Thomas
    ONCOTARGET, 2016, 7 (51): : 84705 - 84717
  • [39] Characteristics and prognosis of young breast cancer patients with low expression of estrogen receptor
    Wang, Shuaibing
    Li, Yang
    Qi, Xiuheng
    Liu, Hong
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (02) : 50 - 57
  • [40] TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer
    Liu, Xiangjuan
    Zhang, Jiahong
    Zhao, Jun
    Cheng, Yan
    Jiang, Dandan
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (08)